HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 207 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2024. The put-call ratio across all filers is 0.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $11 | -8.3% | 367 | +1.1% | 0.01% | -12.5% |
| Q1 2024 | $12 | -93.1% | 363 | -93.3% | 0.01% | -93.3% |
| Q4 2023 | $174 | +13.7% | 5,389 | +15.8% | 0.12% | +3.5% |
| Q3 2023 | $153 | -1.9% | 4,654 | +4.9% | 0.12% | -3.4% |
| Q2 2023 | $156 | +88.0% | 4,437 | +75.2% | 0.12% | +65.3% |
| Q1 2023 | $83 | -51.7% | 2,533 | -18.8% | 0.07% | +2.9% |
| Q4 2022 | $172 | -99.8% | 3,118 | +89.4% | 0.07% | +9.4% |
| Q3 2022 | $73,000 | – | 1,646 | +20475.0% | 0.06% | – |
| Q2 2022 | $0 | -100.0% | 8 | -33.3% | 0.00% | -100.0% |
| Q1 2022 | $1,000 | 0.0% | 12 | -40.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $545,757,000 | 83.25% |
| Nan Fung Group Holdings Ltd | 768,708 | $37,398,000 | 17.74% |
| venBio Partners LLC | 1,544,484 | $75,139,000 | 16.66% |
| Vivo Capital, LLC | 4,570,148 | $222,338,000 | 15.31% |
| HealthInvest Partners AB | 120,000 | $5,838,000 | 9.30% |
| Aisling Capital Management LP | 342,815 | $16,678,000 | 9.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 205,474 | $20,533,000 | 4.63% |
| ASHFORD CAPITAL MANAGEMENT INC | 659,873 | $32,103,000 | 3.46% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $14,595,000 | 2.92% |
| Newlight Partners LP | 651,372 | $31,689,000 | 2.15% |